Woodline Partners LP Molecular Templates, Inc. Transaction History

Woodline Partners LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$3.37 - $6.87 $1.67 Million - $3.41 Million	-496,213 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$5.78 - $7.86 $515,917 - $701,575	-89,259 Reduced 15.25%	496,213 $3.33 Million
Q2 2021 Aug 16, 2021	SELL	$7.82 - $12.44 $4.38 Million - $6.97 Million	-560,041 Reduced 48.89%	585,472 $4.58 Million
Q1 2021 May 17, 2021	BUY	$9.33 - $14.05 $5.86 Million - $8.82 Million	627,843 Added 121.28%	1,145,513 $14.5 Million
Q4 2020 Feb 16, 2021	SELL	$8.48 - $12.23 $5.03 Million - $7.25 Million	-593,145 Reduced 53.4%	517,670 $4.86 Million
Q3 2020 Nov 16, 2020	BUY	$9.99 - $14.41 $5.64 Million - $8.14 Million	564,640 Added 103.38%	1,110,815 $12.1 Million
Q2 2020 Aug 14, 2020	BUY	$12.28 - $17.63 $3.74 Million - $5.37 Million	304,734 Added 126.21%	546,175 $7.53 Million
Q1 2020 May 15, 2020	BUY	$11.31 - $18.26 $2.73 Million - $4.41 Million	241,441 New	241,441 $3.21 Million

499K

Ticker MTEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,351,600
Market Cap $19.2M
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

Stay updated on Woodline Partners LP with notifications on news.